Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KRAS | P01116 | 7/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | TLR9 | Q9NR96 | 4/20 | 0.37 |
| ▸ | EGFR | P00533 | 1/20 | 0.37 |
| ▸ | KIT | P10721 | 1/20 | 0.37 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.36 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.36 |
| ▸ | SRC | P12931 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19617021 | 0.93 | KRAS (0.42) | KRASCYP2D6TSHRFGFR1KDM4E | |
| SCHEMBL19637327 | 0.90 | KRAS (0.56) | KRASEGFR | |
| SCHEMBL30188995 | 0.90 | KRAS (0.56) | KRASEGFR | |
| SCHEMBL19948571 | 0.89 | KRAS (0.45) | KRASTLR9KITTLR7 | |
| SCHEMBL30188700 | 0.89 | KRAS (0.45) | KRASTLR9KITTLR7 | |
| SCHEMBL19637310 | 0.85 | TOP1 (0.40) | KRASCYP2D6TSHRTLR9CHEK1 | |
| SCHEMBL19637302 | 0.83 | KRAS (0.56) | KRAS | |
| SCHEMBL19959300 | 0.82 | KRAS (0.45) | KRASKDM4ETLR9KITTLR7 | |
| SCHEMBL19616719 | 0.81 | KRAS (0.45) | KRAS | |
| SCHEMBL19637181 | 0.81 | KRAS (0.58) | KRAS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017201161-A1 | KRAS G12C INHIBITORS | Mirati Therapeutics, Inc. (US) | 2017-11-23 | — | — | WO | disclosed |